Login / Signup

Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study.

Theresa V StrongJennifer L MillerShawn E McCandlessEvelien GeversJack A YanovskiLisa MatesevacJessica BohonowychShaila BallalKristen YenPatricia HiranoNeil M CowenAnish Bhatnagar
Published in: Journal of neurodevelopmental disorders (2024)
Clinical study C601 was originally registered on ClinicalTrials.gov on February 22, 2018 (NCT03440814). Clinical study C602 was originally registered on ClinicalTrials.gov on October 22, 2018 (NCT03714373). PATH for PWS was originally registered on ClinicalTrials.gov on October 24, 2018 (NCT03718416).
Keyphrases
  • growth hormone
  • case report